Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
20 June 2024 | Story Jacky Tshokwe | Photo Suplied
Dr Mutshidzi Mulondo
Dr Mutshidzi Mulondo’s achievements not only highlight her personal dedication and growth, but further reflect the University of the Free State’s unwavering commitment to Vision 130’s goals of academic excellence, leadership, and global engagement.

The University of the Free State (UFS) takes immense pride in the remarkable achievements of Dr Mutshidzi Mulondo, an academic in the Faculty of Health Sciences. Her international recognition and appointments not only exemplify her dedication to academic excellence and leadership but also reflect the UFS’ commitment to nurturing researchers who are globally competitive and internationally well connected, aligning perfectly with Vision 130.

Dr Mulondo was recently appointed to the International Council of Advisers as council member in the Golden Key International Honour Society. Golden Key, the world's largest collegiate honour society, selects the top 15% of high academic achievers in a college or university. In this role, Dr Mulondo will represent South Africa and oversee more than 20 (all) academic institutional chapters in South Africa. Her passion for academic excellence and leadership development is evident, as she strives to nurture these qualities among students, further ensuring that they remain socially engaged, in the spirit of ubuntu. “Education is one of the keys to eradicating poverty. While academic excellence can set graduates apart, we must continue to encourage and celebrate this excellence among our students and youth – not just this Youth Month but every other month. I am honoured to amplify an organisation such as Golden Key that shares these values,” says Dr Mulondo.

This commitment to academic and leadership excellence is a cornerstone of the UFS’ mission. The strategic objectives aim to enhance research capabilities and promote leadership, creating an environment where students and staff can thrive and make significant contributions to society.

Dr Mulondo’s recent accomplishments extend beyond her council and advisory role. She was awarded an impact-oriented grant for emerging researchers under the University Partnership Initiative, allowing her to strengthen her collaborative research partnership with the Appalachian State University (AppState). As a Public Health visiting scholar at AppState’s Beaver College of Health Sciences, she worked with academic host Dr Tandrea Carter, and collaborators Prof Martie Thompson and Prof Adam Hege. Her visit in the last term of 2023 culminated in a presentation of preliminary findings at the Global Symposium, USA. This public health partnership highlights the continuing collaboration initiated during her time as a Mandela Washington Fellow in 2022. This partnership underscores the UFS’ commitment to global engagement and fostering partnerships that enhance educational and research agenda.

Her global impact is further recognised, as she was selected globally as one of 10 Reimagining Healthcare Scholars by Novartis in 2023. Representing South Africa, she joined young global scholars at the One Young World Summit in the United Kingdom. The summit gathered delegates from 192 countries to address pressing global issues such as mental health, climate change, and food security. “As emerging scholars, it is essential to stay engaged locally and globally if we must remain innovative,” says Dr Mulondo, who is now a One Young World Ambassador. Her participation underscores the UFS’ dedication to nurturing staff members who address global challenges and aligns with the vision of fostering academic excellence and social responsibility.

“It is no surprise that Dr Mulondo has been appointed and selected for these various global roles and accolades, as she has continued to display the UFS Vision 130’s values of academic and leadership excellence on a global stage, further evidenced by her selection to the university’s Emerging Scholar Accelerator Programme (ESAP),” says Prof Joyce Tsoka-Gwegweni, Vice-Dean: Research and Head of Public Health. This advanced residential programme identifies the most promising academics who have obtained a doctoral degree within the last five years. Dr Mulondo’s dedication to academic excellence and leadership is commendable.

Reflecting on her journey as an emerging researcher in the newly established Division of Public Health, Dr Mulondo expressed gratitude for the supportive environment at the UFS. “I am grateful for the enabling environment that the UFS provides to emerging researchers and academics through programmes such as ESAP. I look forward to continued growth and I continue to be fuelled by my favourite passages of Scripture. ‘Let no one despise your youth, but be an example to the believers in word, in conduct, in love, in spirit, in faith and in purity.’ For the people who know their God will truly be strong and will carry out great exploits.” (1 Timothy 4:12; Daniel 11:32).

News Archive

UFS Chemistry wins dti award
2010-11-02

At the awards ceremony are, from the left: Director-General of Trade and Industry Mr Tshediso Matona, Prof. Andreas Roodt and the Deputy-Minister of Trade and Industry, Ms Bongi Maria Ntuli.
Photo: S Osman

The research group of Prof. Andreas Roodt, Head of the Department of Chemistry at the University of the Free State (UFS) in Bloemfontein, won the first prize in the category Development of Small Medium and Micro-Enterprises (SMME) at the annual Department of Trade and Industry’s (dti) award ceremony.

Prof. Roodt received the prize for the high-technology project Development of novel nuclear pharmaceuticals in the Technology and Human Resources for Industry Programme (THRIP).

The Deputy-Minister of Trade and Industry Bongi Maria Ntuli, and Director-General Tshediso Matona presented the prize at the gala dinner held at Gallagher Estate, Gauteng in October 2010.

The dti’s Annual Technology Awards recognise excellence in research and aim to raise awareness on the benefits of using technology to improve the competitiveness of enterprises, within the local and global arena. Individuals and organisations are recognised for their efforts in advancing and promoting technology interests and emerging enterprises.

The technology awards cover the achievements of three of the dti technology programmes collectively, namely THRIP, managed by the National Research Foundation (NRF); the Support Programme for Industrial Innovation (SPII) managed by the Industrial Development Corporation (IDC); and the Small Enterprise Development Agency (seda) Technology Programme (stp).

Prof. Roodt, also vice-president of the European Crystallographic Association, who has just returned from a series of lectures abroad after being elected Fellow of the Royal Society of Chemistry in the UK, has received funding in excess of R3 million over the past two years to set up a specialised laboratory for synthesising active compounds. Key partners in this project are Dr Gerdus Kemp from PETLabs Pharmaceuticals in Pretoria; Prof. Connie Medlen (pharmacologist), recently appointed affiliate professor at UFS Chemistry; as well as Prof. Deon Visser from the Inorganic Chemistry research group at the UFS.

The research aims to produce new nuclear medicinal agents for the early diagnosis of cancer, heart and brain defects, and even HIV/ Aids.

Two doctoral students, Alice Brink and Marietjie Schutte, are currently actively involved in this project. They are the recipients of prestige scholarships introduced by the UFS Rector and Vice-Chancellor, Prof. Jonathan Jansen, under the UFS Research Initiative (the Advanced Biomolecular Systems Cluster) to complete their Ph.D. studies.

Media Release
Issued by: Lacea Loader
Director: Strategic Communication (actg)
Tel: 051 401 2584
Cell: 083 645 2454
E-mail: loaderl@ufs.ac.za  
2 November 2010

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept